243 related articles for article (PubMed ID: 24330074)
21. Modulation of AT-1R/MAPK cascade by an olmesartan treatment attenuates diabetic nephropathy in streptozotocin-induced diabetic mice.
Lakshmanan AP; Thandavarayan RA; Watanabe K; Sari FR; Meilei H; Giridharan VV; Sukumaran V; Soetikno V; Arumugam S; Suzuki K; Kodama M
Mol Cell Endocrinol; 2012 Jan; 348(1):104-11. PubMed ID: 21827824
[TBL] [Abstract][Full Text] [Related]
22. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
Taira M; Toba H; Murakami M; Iga I; Serizawa R; Murata S; Kobara M; Nakata T
Eur J Pharmacol; 2008 Jul; 589(1-3):264-71. PubMed ID: 18582458
[TBL] [Abstract][Full Text] [Related]
23. Targeting JNK by a new curcumin analog to inhibit NF-kB-mediated expression of cell adhesion molecules attenuates renal macrophage infiltration and injury in diabetic mice.
Pan Y; Zhang X; Wang Y; Cai L; Ren L; Tang L; Wang J; Zhao Y; Wang Y; Liu Q; Li X; Liang G
PLoS One; 2013; 8(11):e79084. PubMed ID: 24260158
[TBL] [Abstract][Full Text] [Related]
24. Up-regulation of the Ang II/AT1 receptor may compensate for the loss of gastric antrum ICC via the PI3k/Akt signaling pathway in STZ-induced diabetic mice.
Zhang CM; Huang X; Lu HL; Meng XM; Liu DH; Kim YC; Xu WX
Mol Cell Endocrinol; 2016 Mar; 423():77-86. PubMed ID: 26773730
[TBL] [Abstract][Full Text] [Related]
25. Differential regulation of angiotensin converting enzyme 2 and nuclear factor-κB by angiotensin II receptor subtypes in type 2 diabetic kidney.
Pandey A; Goru SK; Kadakol A; Malek V; Gaikwad AB
Biochimie; 2015 Nov; 118():71-81. PubMed ID: 26271886
[TBL] [Abstract][Full Text] [Related]
26. The protective effects of beta-casomorphin-7 against glucose -induced renal oxidative stress in vivo and vitro.
Zhang W; Miao J; Wang S; Zhang Y
PLoS One; 2013; 8(5):e63472. PubMed ID: 23658831
[TBL] [Abstract][Full Text] [Related]
27. Upregulation of renal renin-angiotensin system in mouse diabetic nephropathy.
Tamura J; Konno A; Hashimoto Y; Kon Y
Jpn J Vet Res; 2005 Aug; 53(1-2):13-26. PubMed ID: 16190318
[TBL] [Abstract][Full Text] [Related]
28. Vaccination against type 1 angiotensin receptor prevents streptozotocin-induced diabetic nephropathy.
Ding D; Du Y; Qiu Z; Yan S; Chen F; Wang M; Yang S; Zhou Y; Hu X; Deng Y; Wang S; Wang L; Zhang H; Wu H; Yu X; Zhou Z; Liao Y; Chen X
J Mol Med (Berl); 2016 Feb; 94(2):207-18. PubMed ID: 26407577
[TBL] [Abstract][Full Text] [Related]
29. Angiotensin II up-regulates angiotensin I-converting enzyme (ACE), but down-regulates ACE2 via the AT1-ERK/p38 MAP kinase pathway.
Koka V; Huang XR; Chung AC; Wang W; Truong LD; Lan HY
Am J Pathol; 2008 May; 172(5):1174-83. PubMed ID: 18403595
[TBL] [Abstract][Full Text] [Related]
30. AAV8-Mediated Angiotensin-Converting Enzyme 2 Gene Delivery Prevents Experimental Autoimmune Uveitis by Regulating MAPK, NF-κB and STAT3 Pathways.
Qiu Y; Tao L; Zheng S; Lin R; Fu X; Chen Z; Lei C; Wang J; Li H; Li Q; Lei B
Sci Rep; 2016 Aug; 6():31912. PubMed ID: 27558087
[TBL] [Abstract][Full Text] [Related]
31. Long-term therapeutic effect of vitamin D analog doxercalciferol on diabetic nephropathy: strong synergism with AT1 receptor antagonist.
Zhang Y; Deb DK; Kong J; Ning G; Wang Y; Li G; Chen Y; Zhang Z; Strugnell S; Sabbagh Y; Arbeeny C; Li YC
Am J Physiol Renal Physiol; 2009 Sep; 297(3):F791-801. PubMed ID: 19535571
[TBL] [Abstract][Full Text] [Related]
32. Angiotensin-converting enzyme inhibition and angiotensin AT1 receptor blockade downregulate angiotensin-converting enzyme expression and attenuate renal injury in streptozotocin-induced diabetic rats.
Motawi TK; El-Maraghy SA; Senousy MA
J Biochem Mol Toxicol; 2013 Jul; 27(7):378-87. PubMed ID: 23733546
[TBL] [Abstract][Full Text] [Related]
33. Calcitriol regulates angiotensin-converting enzyme and angiotensin converting-enzyme 2 in diabetic kidney disease.
Lin M; Gao P; Zhao T; He L; Li M; Li Y; Shui H; Wu X
Mol Biol Rep; 2016 May; 43(5):397-406. PubMed ID: 26968558
[TBL] [Abstract][Full Text] [Related]
34. NaHS restores the vascular alterations in the renin-angiotensin system induced by hyperglycemia in rats.
Silva-Velasco DL; Beltran-Ornelas JH; Tapia-Martínez J; Sánchez-López A; de la Cruz SH; Cervantes-Pérez LG; Del Valle-Mondragón L; Sánchez-Mendoza A; Centurión D
Peptides; 2023 Jun; 164():171001. PubMed ID: 36990388
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of the monocarbonyl curcumin analog C66 in the reduction of diabetes-associated cardiovascular and kidney complications.
Mladenov M; Bogdanov J; Bogdanov B; Hadzi-Petrushev N; Kamkin A; Stojchevski R; Avtanski D
Mol Med; 2022 Oct; 28(1):129. PubMed ID: 36316651
[TBL] [Abstract][Full Text] [Related]
36. Glomerular renin angiotensin system in streptozotocin diabetic and Zucker diabetic fatty rats.
Leehey DJ; Singh AK; Bast JP; Sethupathi P; Singh R
Transl Res; 2008 Apr; 151(4):208-16. PubMed ID: 18355768
[TBL] [Abstract][Full Text] [Related]
37. Role of angiotensin II in diabetic nephropathy.
Kennefick TM; Anderson S
Semin Nephrol; 1997 Sep; 17(5):441-7. PubMed ID: 9316212
[TBL] [Abstract][Full Text] [Related]
38. Perindopril treatment in streptozotocin induced diabetic nephropaty.
Trojacanec J; Zafirov D; Labacevski N; Jakjovski K; Zdravkovski P; Trojacanec P; Petrusevska G
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2013; 34(1):99-108. PubMed ID: 23928803
[TBL] [Abstract][Full Text] [Related]
39. CDK9 inhibition improves diabetic nephropathy by reducing inflammation in the kidneys.
Yang X; Luo W; Li L; Hu X; Xu M; Wang Y; Feng J; Qian J; Guan X; Zhao Y; Liang G
Toxicol Appl Pharmacol; 2021 Apr; 416():115465. PubMed ID: 33631230
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of heterogeneous nuclear ribonucleoprotein F stimulates renal Ace-2 gene expression and prevents TGF-β1-induced kidney injury in a mouse model of diabetes.
Lo CS; Shi Y; Chang SY; Abdo S; Chenier I; Filep JG; Ingelfinger JR; Zhang SL; Chan JS
Diabetologia; 2015 Oct; 58(10):2443-54. PubMed ID: 26232095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
